{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:49:28Z","timestamp":1791888568434,"version":"4.3.4"},"reference-count":0,"publisher":"Czech Society of Ophthalmology of the CzMA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Mirvetuximab soravtansine is an antibody\u2013drug conjugate targeting folate receptor alpha (FR\u03b1), which is used in the treatment of platinum-resistant ovarian cancer. Its administration is associated with a distinct spectrum of ocular adverse events, representing a clinically relevant limitation of therapy. The most common manifestations include keratopathy, blurred vision, and dry eye symptoms. These effects are generally reversible and manageable upon appropriate ophthalmologic monitoring. This review summarizes the current knowledge regarding the mechanisms, clinical presentation, incidence, prevention, and management of mirvetuximab-associated ocular toxicity.<\/jats:p>","DOI":"10.31348\/2026\/27","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:20:01Z","timestamp":1791886801000},"source":"Crossref","is-referenced-by-count":0,"title":["Mirvetuximab Soravtansine and its Treatment-Associated Ocular Adverse Effects. A Review of the Current Knowledge"],"prefix":"10.31348","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1279-4074","authenticated-orcid":false,"given":"Pavel","family":"Studen\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkela","family":"Hrdli\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16213","published-online":{"date-parts":[[2026,7,23]]},"container-title":["Czech and Slovak Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:20:02Z","timestamp":1791886802000},"score":1,"resource":{"primary":{"URL":"https:\/\/cs-ophthalmology.cz\/en\/journal\/articles\/569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31348\/2026\/27","relation":{},"ISSN":["1211-9059","1805-4447"],"issn-type":[{"value":"1211-9059","type":"print"},{"value":"1805-4447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}